Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Asthma, Aspirin-Induced | 63 | 2024 | 204 | 24.340 |
Why?
|
Nasal Polyps | 47 | 2025 | 412 | 12.260 |
Why?
|
Sinusitis | 48 | 2024 | 995 | 9.760 |
Why?
|
Aspirin | 58 | 2024 | 3134 | 7.650 |
Why?
|
Rhinitis | 34 | 2024 | 752 | 7.460 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 30 | 2024 | 2268 | 4.810 |
Why?
|
Drug Hypersensitivity | 17 | 2024 | 902 | 3.860 |
Why?
|
Desensitization, Immunologic | 18 | 2023 | 544 | 3.710 |
Why?
|
Eosinophils | 7 | 2024 | 945 | 2.660 |
Why?
|
Respiratory Tract Diseases | 10 | 2023 | 744 | 2.630 |
Why?
|
Biological Products | 10 | 2023 | 942 | 2.400 |
Why?
|
Mast Cells | 14 | 2025 | 1412 | 2.290 |
Why?
|
Asthma | 21 | 2024 | 6270 | 1.850 |
Why?
|
Dinoprostone | 10 | 2024 | 591 | 1.600 |
Why?
|
Cyclooxygenase Inhibitors | 7 | 2021 | 361 | 1.550 |
Why?
|
Hypersensitivity | 6 | 2024 | 1168 | 1.540 |
Why?
|
Leukotrienes | 9 | 2022 | 232 | 1.520 |
Why?
|
Immunoglobulin E | 6 | 2024 | 1481 | 1.510 |
Why?
|
Receptors, Leukotriene | 6 | 2019 | 97 | 1.480 |
Why?
|
Allergens | 11 | 2023 | 1436 | 1.470 |
Why?
|
Respiration Disorders | 3 | 2023 | 362 | 1.190 |
Why?
|
Chronic Disease | 29 | 2024 | 9347 | 1.100 |
Why?
|
Interleukin-4 Receptor alpha Subunit | 3 | 2024 | 57 | 1.100 |
Why?
|
Eosinophilia | 5 | 2018 | 556 | 1.020 |
Why?
|
Chemokine CCL17 | 1 | 2024 | 25 | 0.920 |
Why?
|
Eicosanoids | 4 | 2023 | 284 | 0.920 |
Why?
|
Leukotriene E4 | 7 | 2023 | 75 | 0.920 |
Why?
|
Oncostatin M | 1 | 2024 | 42 | 0.910 |
Why?
|
Endrin | 1 | 2023 | 4 | 0.900 |
Why?
|
Interleukin-5 Receptor alpha Subunit | 2 | 2021 | 17 | 0.880 |
Why?
|
Anti-Asthmatic Agents | 4 | 2024 | 572 | 0.840 |
Why?
|
Interleukin-13 | 3 | 2024 | 388 | 0.840 |
Why?
|
Chemokine CXCL10 | 1 | 2024 | 310 | 0.820 |
Why?
|
Tryptases | 3 | 2022 | 177 | 0.780 |
Why?
|
Basophils | 2 | 2021 | 392 | 0.720 |
Why?
|
Receptors, Prostaglandin E, EP2 Subtype | 4 | 2024 | 48 | 0.710 |
Why?
|
Blood Platelets | 7 | 2019 | 2464 | 0.700 |
Why?
|
Prostaglandin D2 | 3 | 2016 | 109 | 0.640 |
Why?
|
Cysteine | 3 | 2015 | 898 | 0.640 |
Why?
|
Respiratory System | 2 | 2022 | 559 | 0.630 |
Why?
|
Humans | 128 | 2025 | 765968 | 0.630 |
Why?
|
Cryopreservation | 1 | 2023 | 728 | 0.600 |
Why?
|
Receptors, Purinergic P2Y12 | 1 | 2018 | 117 | 0.570 |
Why?
|
Accidents | 1 | 2018 | 164 | 0.570 |
Why?
|
Acetates | 1 | 2018 | 313 | 0.550 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2019 | 318 | 0.550 |
Why?
|
Adult | 55 | 2024 | 223044 | 0.540 |
Why?
|
Diet Therapy | 1 | 2017 | 149 | 0.530 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2021 | 1167 | 0.530 |
Why?
|
Back Pain | 1 | 2020 | 544 | 0.530 |
Why?
|
Leukocyte Count | 4 | 2024 | 1602 | 0.520 |
Why?
|
Cyclooxygenase 1 | 4 | 2022 | 98 | 0.510 |
Why?
|
Coronary Vasospasm | 1 | 2016 | 81 | 0.510 |
Why?
|
Purinergic P2Y Receptor Antagonists | 1 | 2018 | 284 | 0.500 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 1 | 2019 | 325 | 0.500 |
Why?
|
Nasal Mucosa | 4 | 2024 | 416 | 0.500 |
Why?
|
Opioid-Related Disorders | 2 | 2020 | 2178 | 0.500 |
Why?
|
Middle Aged | 51 | 2024 | 223009 | 0.500 |
Why?
|
Exanthema | 1 | 2020 | 502 | 0.500 |
Why?
|
Plasma | 1 | 2018 | 579 | 0.490 |
Why?
|
Female | 63 | 2025 | 396112 | 0.470 |
Why?
|
Inflammation Mediators | 4 | 2024 | 1884 | 0.470 |
Why?
|
Granulocytes | 2 | 2014 | 549 | 0.470 |
Why?
|
Respiratory Hypersensitivity | 1 | 2016 | 271 | 0.460 |
Why?
|
Interleukin-6 | 1 | 2024 | 3222 | 0.450 |
Why?
|
Male | 59 | 2024 | 363698 | 0.440 |
Why?
|
Oxazoles | 1 | 2015 | 198 | 0.440 |
Why?
|
Airway Obstruction | 1 | 2018 | 665 | 0.430 |
Why?
|
Interleukin-5 | 4 | 2023 | 268 | 0.420 |
Why?
|
Prostaglandins | 3 | 2023 | 396 | 0.420 |
Why?
|
Quinolines | 1 | 2018 | 769 | 0.420 |
Why?
|
Respiratory Function Tests | 3 | 2024 | 1693 | 0.410 |
Why?
|
Analgesics, Opioid | 3 | 2023 | 3835 | 0.400 |
Why?
|
Forced Expiratory Volume | 5 | 2021 | 1828 | 0.390 |
Why?
|
Respiratory Tract Infections | 1 | 2019 | 1008 | 0.380 |
Why?
|
Platelet Activation | 5 | 2023 | 645 | 0.360 |
Why?
|
Thiophenes | 1 | 2015 | 569 | 0.360 |
Why?
|
Leukotriene C4 | 4 | 2019 | 79 | 0.350 |
Why?
|
Fibroblasts | 2 | 2024 | 4159 | 0.350 |
Why?
|
Antioxidants | 1 | 2018 | 1670 | 0.350 |
Why?
|
Stem Cell Factor | 1 | 2011 | 194 | 0.350 |
Why?
|
Peanut Hypersensitivity | 2 | 2024 | 217 | 0.350 |
Why?
|
Administration, Oral | 5 | 2023 | 4015 | 0.340 |
Why?
|
Fatty Acids | 1 | 2017 | 1806 | 0.330 |
Why?
|
Cytokines | 4 | 2024 | 7421 | 0.320 |
Why?
|
Receptors, IgE | 1 | 2011 | 374 | 0.320 |
Why?
|
Chest Pain | 1 | 2016 | 1100 | 0.320 |
Why?
|
Signal Transduction | 8 | 2025 | 23601 | 0.310 |
Why?
|
Aged | 30 | 2024 | 171117 | 0.310 |
Why?
|
Cell Adhesion Molecules | 1 | 2014 | 1612 | 0.300 |
Why?
|
Receptors, Thromboxane | 3 | 2023 | 30 | 0.300 |
Why?
|
Immunoglobulin G | 1 | 2020 | 4528 | 0.300 |
Why?
|
Ethanol | 1 | 2014 | 1323 | 0.290 |
Why?
|
Thromboxane A2 | 4 | 2015 | 87 | 0.280 |
Why?
|
Quality of Life | 10 | 2024 | 13462 | 0.260 |
Why?
|
Leukotriene B4 | 3 | 2017 | 281 | 0.250 |
Why?
|
Inflammation | 8 | 2025 | 10850 | 0.250 |
Why?
|
Drug Therapy, Combination | 1 | 2015 | 6309 | 0.240 |
Why?
|
Sequence Analysis, RNA | 3 | 2023 | 2034 | 0.240 |
Why?
|
Piperazines | 1 | 2015 | 2549 | 0.230 |
Why?
|
Cells, Cultured | 8 | 2024 | 18973 | 0.230 |
Why?
|
Th2 Cells | 2 | 2024 | 1075 | 0.220 |
Why?
|
Lymphoid Enhancer-Binding Factor 1 | 1 | 2024 | 84 | 0.220 |
Why?
|
Leukocytes | 1 | 2012 | 2027 | 0.220 |
Why?
|
T Cell Transcription Factor 1 | 1 | 2024 | 72 | 0.220 |
Why?
|
Immunization | 2 | 2018 | 1219 | 0.220 |
Why?
|
Eustachian Tube | 1 | 2024 | 99 | 0.210 |
Why?
|
Thromboxanes | 1 | 2023 | 45 | 0.210 |
Why?
|
Olfactory Mucosa | 1 | 2024 | 101 | 0.210 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2024 | 175 | 0.210 |
Why?
|
Syndrome | 2 | 2020 | 3271 | 0.210 |
Why?
|
Ear Diseases | 1 | 2024 | 179 | 0.200 |
Why?
|
Multipotent Stem Cells | 1 | 2024 | 199 | 0.200 |
Why?
|
Interleukin-4 | 4 | 2023 | 1162 | 0.200 |
Why?
|
Lung | 7 | 2024 | 10033 | 0.190 |
Why?
|
Homeostasis | 3 | 2023 | 3336 | 0.190 |
Why?
|
Nasal Provocation Tests | 1 | 2021 | 9 | 0.190 |
Why?
|
Macrophages | 3 | 2024 | 5772 | 0.190 |
Why?
|
Animals | 23 | 2024 | 168764 | 0.190 |
Why?
|
Receptors, Interleukin-13 | 1 | 2021 | 13 | 0.190 |
Why?
|
Intramolecular Oxidoreductases | 4 | 2015 | 105 | 0.180 |
Why?
|
Antigens, Dermatophagoides | 2 | 2012 | 101 | 0.180 |
Why?
|
Immunotherapy | 2 | 2023 | 4752 | 0.180 |
Why?
|
Nasal Sprays | 1 | 2021 | 27 | 0.180 |
Why?
|
Chymases | 2 | 2025 | 85 | 0.180 |
Why?
|
Arthroplasty | 1 | 2023 | 306 | 0.170 |
Why?
|
Biological Factors | 1 | 2021 | 155 | 0.170 |
Why?
|
Cell Proliferation | 5 | 2024 | 10429 | 0.170 |
Why?
|
Placebos | 2 | 2021 | 1659 | 0.160 |
Why?
|
Carnitine | 1 | 2020 | 253 | 0.160 |
Why?
|
Job Satisfaction | 1 | 2003 | 549 | 0.160 |
Why?
|
Young Adult | 10 | 2024 | 59889 | 0.160 |
Why?
|
Double-Blind Method | 4 | 2024 | 12437 | 0.160 |
Why?
|
Cyclooxygenase 2 | 2 | 2019 | 594 | 0.160 |
Why?
|
Epithelial Cells | 4 | 2024 | 3681 | 0.160 |
Why?
|
Hymen | 1 | 1998 | 18 | 0.160 |
Why?
|
Enterocytes | 1 | 2020 | 220 | 0.150 |
Why?
|
Retrospective Studies | 10 | 2023 | 81514 | 0.150 |
Why?
|
Bronchiectasis | 1 | 2020 | 141 | 0.150 |
Why?
|
Single-Cell Analysis | 4 | 2023 | 2535 | 0.150 |
Why?
|
Pulmonary Eosinophilia | 3 | 2015 | 78 | 0.150 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2020 | 323 | 0.150 |
Why?
|
Treatment Outcome | 12 | 2024 | 65188 | 0.150 |
Why?
|
Mice, Knockout | 8 | 2024 | 14448 | 0.150 |
Why?
|
Sulfides | 1 | 2018 | 165 | 0.140 |
Why?
|
France | 1 | 2019 | 495 | 0.140 |
Why?
|
HMGB1 Protein | 1 | 2019 | 139 | 0.140 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2021 | 10729 | 0.140 |
Why?
|
Neutrophils | 2 | 2024 | 3776 | 0.140 |
Why?
|
Cross Reactions | 1 | 2019 | 824 | 0.140 |
Why?
|
Cyclopropanes | 1 | 2018 | 437 | 0.140 |
Why?
|
Immune Tolerance | 2 | 2024 | 2324 | 0.140 |
Why?
|
Goblet Cells | 1 | 2020 | 301 | 0.140 |
Why?
|
Transforming Growth Factor beta | 1 | 2025 | 1995 | 0.140 |
Why?
|
Expert Testimony | 1 | 1998 | 266 | 0.140 |
Why?
|
Skin Test End-Point Titration | 1 | 1996 | 1 | 0.130 |
Why?
|
Mice | 17 | 2024 | 81819 | 0.130 |
Why?
|
Postpartum Period | 1 | 2023 | 1205 | 0.130 |
Why?
|
Plasma Cells | 1 | 2020 | 591 | 0.130 |
Why?
|
Paranasal Sinuses | 1 | 2019 | 267 | 0.130 |
Why?
|
Group V Phospholipases A2 | 1 | 2016 | 23 | 0.130 |
Why?
|
Prostaglandins D | 1 | 2015 | 28 | 0.130 |
Why?
|
Interferon Type I | 1 | 2020 | 567 | 0.130 |
Why?
|
Epitopes | 1 | 2022 | 2523 | 0.130 |
Why?
|
Virginia | 1 | 2016 | 115 | 0.130 |
Why?
|
Stress, Psychological | 2 | 2003 | 4533 | 0.130 |
Why?
|
Hypnosis | 1 | 1996 | 83 | 0.130 |
Why?
|
Endoscopy | 3 | 2021 | 1841 | 0.120 |
Why?
|
Anesthesiology | 2 | 2003 | 1135 | 0.120 |
Why?
|
Morbidity | 1 | 2020 | 1749 | 0.120 |
Why?
|
Eosinophilic Esophagitis | 1 | 2018 | 206 | 0.120 |
Why?
|
Platelet Activating Factor | 1 | 2015 | 142 | 0.120 |
Why?
|
Respiratory Mucosa | 1 | 2018 | 438 | 0.120 |
Why?
|
Adrenal Cortex Hormones | 3 | 2022 | 1880 | 0.120 |
Why?
|
Early Diagnosis | 1 | 2020 | 1187 | 0.120 |
Why?
|
Occupational Diseases | 1 | 2003 | 1456 | 0.120 |
Why?
|
Transglutaminases | 1 | 2016 | 201 | 0.120 |
Why?
|
Drug Utilization | 1 | 2020 | 1187 | 0.110 |
Why?
|
Histamine | 1 | 1996 | 497 | 0.110 |
Why?
|
Sex Offenses | 1 | 1998 | 356 | 0.110 |
Why?
|
Burnout, Professional | 1 | 2003 | 711 | 0.110 |
Why?
|
Serine Endopeptidases | 2 | 2020 | 1024 | 0.110 |
Why?
|
Immunity, Innate | 2 | 2016 | 3081 | 0.110 |
Why?
|
Outpatients | 1 | 2021 | 1595 | 0.110 |
Why?
|
Cerebrospinal Fluid Rhinorrhea | 1 | 2014 | 86 | 0.110 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2022 | 2570 | 0.110 |
Why?
|
Endothelin-1 | 1 | 2015 | 295 | 0.110 |
Why?
|
Medical History Taking | 1 | 2017 | 777 | 0.110 |
Why?
|
Pneumonia | 3 | 2024 | 2157 | 0.110 |
Why?
|
Drug Tolerance | 1 | 2015 | 363 | 0.100 |
Why?
|
Patient Care | 1 | 2019 | 629 | 0.100 |
Why?
|
Acetylation | 1 | 2016 | 1053 | 0.100 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2024 | 4348 | 0.100 |
Why?
|
CHO Cells | 2 | 2012 | 1372 | 0.100 |
Why?
|
Pain, Postoperative | 1 | 2023 | 1772 | 0.100 |
Why?
|
Severity of Illness Index | 5 | 2024 | 15880 | 0.100 |
Why?
|
Child | 7 | 2024 | 80564 | 0.100 |
Why?
|
Antibodies | 1 | 2020 | 2417 | 0.100 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2012 | 318 | 0.100 |
Why?
|
Cross-Over Studies | 1 | 2018 | 2108 | 0.100 |
Why?
|
Adolescent | 11 | 2024 | 88835 | 0.100 |
Why?
|
Cricetinae | 2 | 2012 | 2411 | 0.090 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2014 | 484 | 0.090 |
Why?
|
Arachidonate 5-Lipoxygenase | 1 | 2012 | 128 | 0.090 |
Why?
|
Bronchoconstriction | 1 | 2012 | 141 | 0.090 |
Why?
|
Disease Management | 2 | 2019 | 2535 | 0.090 |
Why?
|
Anti-Inflammatory Agents | 1 | 2020 | 1808 | 0.090 |
Why?
|
Health Services Needs and Demand | 1 | 2019 | 1406 | 0.090 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2016 | 777 | 0.090 |
Why?
|
Phenotype | 2 | 2020 | 16721 | 0.090 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 1999 | 1484 | 0.090 |
Why?
|
Cell Differentiation | 2 | 2025 | 11641 | 0.090 |
Why?
|
Prospective Studies | 5 | 2024 | 54802 | 0.090 |
Why?
|
Cyclic AMP | 1 | 2014 | 1467 | 0.080 |
Why?
|
Respiratory Sounds | 1 | 2014 | 705 | 0.080 |
Why?
|
Glutathione Transferase | 1 | 2011 | 562 | 0.080 |
Why?
|
Pain | 1 | 2024 | 5077 | 0.080 |
Why?
|
Mental Health | 1 | 2022 | 3278 | 0.070 |
Why?
|
Massachusetts | 1 | 2020 | 8875 | 0.070 |
Why?
|
Integrins | 1 | 2012 | 840 | 0.070 |
Why?
|
Caregivers | 1 | 1999 | 2307 | 0.070 |
Why?
|
Flow Cytometry | 2 | 2021 | 5881 | 0.060 |
Why?
|
Epigenesis, Genetic | 2 | 2018 | 3819 | 0.060 |
Why?
|
Dyspnea | 1 | 2014 | 1352 | 0.060 |
Why?
|
Communication | 1 | 2020 | 3916 | 0.060 |
Why?
|
Boston | 2 | 2016 | 9338 | 0.060 |
Why?
|
Reproducibility of Results | 1 | 2024 | 20124 | 0.060 |
Why?
|
Stem Cells | 1 | 2018 | 3540 | 0.060 |
Why?
|
Histones | 1 | 2016 | 2584 | 0.060 |
Why?
|
Cathepsin G | 1 | 2025 | 41 | 0.060 |
Why?
|
Prevalence | 1 | 2022 | 15842 | 0.060 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 5786 | 0.060 |
Why?
|
Comorbidity | 1 | 2019 | 10563 | 0.060 |
Why?
|
Lipid Metabolism | 1 | 2012 | 1892 | 0.060 |
Why?
|
Case-Control Studies | 3 | 2018 | 22223 | 0.060 |
Why?
|
Enzyme Inhibitors | 1 | 2015 | 3715 | 0.060 |
Why?
|
Pilot Projects | 1 | 2017 | 8733 | 0.060 |
Why?
|
Body Mass Index | 1 | 2022 | 13039 | 0.060 |
Why?
|
Antibody-Producing Cells | 1 | 2023 | 138 | 0.050 |
Why?
|
Clinical Trials as Topic | 2 | 2020 | 8041 | 0.050 |
Why?
|
Cell Culture Techniques | 1 | 2011 | 1652 | 0.050 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2013 | 2770 | 0.050 |
Why?
|
Blotting, Western | 1 | 2011 | 5020 | 0.050 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2010 | 1499 | 0.050 |
Why?
|
Bone Marrow Cells | 1 | 2011 | 2412 | 0.050 |
Why?
|
Cell Movement | 1 | 2015 | 5194 | 0.050 |
Why?
|
Antibodies, Monoclonal | 2 | 2019 | 9249 | 0.050 |
Why?
|
Algorithms | 3 | 2020 | 14071 | 0.050 |
Why?
|
Bronchial Hyperreactivity | 2 | 2017 | 300 | 0.050 |
Why?
|
Ovalbumin | 2 | 2015 | 674 | 0.050 |
Why?
|
Gene Expression | 1 | 2015 | 7584 | 0.050 |
Why?
|
Cell Line | 2 | 2020 | 15543 | 0.050 |
Why?
|
Peptide Fragments | 1 | 2015 | 5125 | 0.050 |
Why?
|
Drug Administration Schedule | 2 | 2024 | 4850 | 0.050 |
Why?
|
Pregnancy | 1 | 2023 | 30260 | 0.050 |
Why?
|
Aged, 80 and over | 4 | 2024 | 59489 | 0.050 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2023 | 457 | 0.050 |
Why?
|
DNA Methylation | 1 | 2016 | 4424 | 0.050 |
Why?
|
Nasal Lavage Fluid | 1 | 2021 | 17 | 0.050 |
Why?
|
Finland | 1 | 2022 | 608 | 0.050 |
Why?
|
Risk Factors | 4 | 2020 | 74840 | 0.050 |
Why?
|
RNA, Messenger | 1 | 2016 | 12768 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 1 | 2017 | 5696 | 0.040 |
Why?
|
Interleukin-18 | 1 | 2022 | 251 | 0.040 |
Why?
|
Mice, Inbred C57BL | 4 | 2024 | 22332 | 0.040 |
Why?
|
National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2020 | 62 | 0.040 |
Why?
|
Intercellular Adhesion Molecule-1 | 2 | 2015 | 1132 | 0.040 |
Why?
|
Antineoplastic Agents | 2 | 2016 | 13648 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2023 | 12240 | 0.040 |
Why?
|
Oxidative Stress | 1 | 2011 | 3141 | 0.040 |
Why?
|
National Health Insurance, United States | 1 | 2019 | 100 | 0.040 |
Why?
|
Australia | 1 | 2003 | 1258 | 0.040 |
Why?
|
Administration, Intranasal | 1 | 2021 | 482 | 0.040 |
Why?
|
Receptor, Insulin | 1 | 2023 | 837 | 0.040 |
Why?
|
Medical Staff, Hospital | 1 | 2003 | 601 | 0.040 |
Why?
|
Injections, Subcutaneous | 1 | 2019 | 682 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 2016 | 11888 | 0.040 |
Why?
|
Arthralgia | 1 | 2022 | 459 | 0.040 |
Why?
|
Up-Regulation | 2 | 2020 | 4137 | 0.040 |
Why?
|
Antigens | 1 | 2023 | 1438 | 0.040 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2021 | 878 | 0.030 |
Why?
|
Bronchial Provocation Tests | 1 | 2017 | 217 | 0.030 |
Why?
|
Methacholine Chloride | 1 | 2017 | 220 | 0.030 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2020 | 791 | 0.030 |
Why?
|
Receptors, Virus | 1 | 2020 | 651 | 0.030 |
Why?
|
Personality | 1 | 1999 | 560 | 0.030 |
Why?
|
Nasal Obstruction | 1 | 2018 | 162 | 0.030 |
Why?
|
Child Abuse, Sexual | 1 | 1998 | 397 | 0.030 |
Why?
|
Olfaction Disorders | 1 | 2018 | 223 | 0.030 |
Why?
|
Receptors, Prostaglandin | 1 | 2015 | 54 | 0.030 |
Why?
|
Hyperplasia | 1 | 2018 | 1144 | 0.030 |
Why?
|
T-Lymphocyte Subsets | 1 | 2023 | 1811 | 0.030 |
Why?
|
Relaxation Therapy | 1 | 1996 | 180 | 0.030 |
Why?
|
Irritable Mood | 1 | 1996 | 196 | 0.030 |
Why?
|
Internal-External Control | 1 | 1996 | 347 | 0.030 |
Why?
|
Leukotriene Antagonists | 1 | 2015 | 124 | 0.030 |
Why?
|
Receptors, Thromboxane A2, Prostaglandin H2 | 1 | 2013 | 10 | 0.030 |
Why?
|
Leukotriene D4 | 1 | 2013 | 33 | 0.030 |
Why?
|
Databases, Factual | 2 | 2019 | 8067 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 3807 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2016 | 15747 | 0.030 |
Why?
|
Platelet Factor 4 | 1 | 2013 | 132 | 0.030 |
Why?
|
Macaca mulatta | 1 | 2020 | 2341 | 0.030 |
Why?
|
Cell Count | 1 | 2017 | 1823 | 0.030 |
Why?
|
Health Surveys | 1 | 2003 | 4056 | 0.030 |
Why?
|
Receptors, Prostaglandin E, EP1 Subtype | 1 | 2012 | 9 | 0.030 |
Why?
|
Autocrine Communication | 1 | 2013 | 167 | 0.030 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2015 | 755 | 0.030 |
Why?
|
Adenosine Diphosphate | 1 | 2013 | 419 | 0.030 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2015 | 694 | 0.030 |
Why?
|
Receptors, Purinergic P2 | 1 | 2013 | 149 | 0.020 |
Why?
|
Airway Resistance | 1 | 2013 | 407 | 0.020 |
Why?
|
United States | 4 | 2021 | 72903 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2023 | 3596 | 0.020 |
Why?
|
Reference Values | 1 | 1998 | 4908 | 0.020 |
Why?
|
P-Selectin | 1 | 2013 | 597 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2015 | 990 | 0.020 |
Why?
|
Consensus | 1 | 2021 | 3202 | 0.020 |
Why?
|
Platelet-Rich Plasma | 1 | 2013 | 179 | 0.020 |
Why?
|
Cost of Illness | 1 | 2020 | 1950 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2024 | 3111 | 0.020 |
Why?
|
Infant | 2 | 2024 | 36386 | 0.020 |
Why?
|
Mycobacterium tuberculosis | 1 | 2020 | 1917 | 0.020 |
Why?
|
Sex Factors | 1 | 2003 | 10603 | 0.020 |
Why?
|
Cricetulus | 1 | 2011 | 805 | 0.020 |
Why?
|
Influenza, Human | 1 | 2020 | 1539 | 0.020 |
Why?
|
Child, Preschool | 2 | 2024 | 42500 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2015 | 1192 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2024 | 14751 | 0.020 |
Why?
|
Analysis of Variance | 1 | 1996 | 6203 | 0.020 |
Why?
|
Attitude to Health | 1 | 1996 | 2020 | 0.020 |
Why?
|
Tuberculosis | 1 | 2020 | 2012 | 0.020 |
Why?
|
Insurance, Health | 1 | 2019 | 2521 | 0.020 |
Why?
|
Bone Marrow Transplantation | 1 | 2015 | 2729 | 0.020 |
Why?
|
Regression Analysis | 1 | 1996 | 6322 | 0.020 |
Why?
|
Skin Tests | 1 | 2008 | 630 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2018 | 7599 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 10383 | 0.010 |
Why?
|
Computational Biology | 1 | 2016 | 3559 | 0.010 |
Why?
|
Health Care Costs | 1 | 2016 | 3242 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2024 | 39193 | 0.010 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3100 | 0.010 |
Why?
|
Clinical Protocols | 1 | 2008 | 1441 | 0.010 |
Why?
|
Age Factors | 2 | 2015 | 18380 | 0.010 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3223 | 0.010 |
Why?
|
Disease Progression | 1 | 2019 | 13632 | 0.010 |
Why?
|
Incidence | 1 | 2020 | 21480 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2011 | 6220 | 0.010 |
Why?
|
Physicians | 1 | 1999 | 4588 | 0.010 |
Why?
|
Cohort Studies | 1 | 2024 | 41649 | 0.010 |
Why?
|
Blood Pressure | 1 | 1996 | 8532 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8703 | 0.010 |
Why?
|
Personality Tests | 1 | 1999 | 80 | 0.010 |
Why?
|
Character | 1 | 1999 | 26 | 0.010 |
Why?
|
New Zealand | 1 | 1999 | 359 | 0.010 |
Why?
|
Registries | 1 | 2015 | 8297 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15398 | 0.010 |
Why?
|
Temperament | 1 | 1999 | 299 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2013 | 7851 | 0.010 |
Why?
|
Personality Disorders | 1 | 1999 | 727 | 0.010 |
Why?
|
Prognosis | 1 | 2015 | 29922 | 0.010 |
Why?
|
HIV Infections | 1 | 2020 | 17533 | 0.010 |
Why?
|
Neoplasms | 1 | 2016 | 22340 | 0.000 |
Why?
|